title: [Tuberculous spinal arachnoiditis. Value of intrathecal corticosteroid therapy].
authors.forename: F
authors.initials: F
authors.lastname: Bricaire
authors.forename: D
authors.initials: D
authors.lastname: Salmon
authors.forename: P
authors.initials: P
authors.lastname: Soccoja
authors.forename: R
authors.initials: R
authors.lastname: Zhiri
authors.forename: J L
authors.initials: JL
authors.lastname: Vilde
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D001100:Arachnoiditis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007278:Injections, Spinal; D008775:Methylprednisolone / Q000008:administration & dosage; D014390:Tuberculosis, Meningeal / Q000188:drug therapy*
chemical_list: D000305:Adrenal Cortex Hormones; D000995:Antitubercular Agents; D008775:Methylprednisolone
vernacular_title: Arachnoïdite spinale tuberculeuse. Intérêt de la corticothérapie par voie intrathécale.